Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Clinical trial NCT04564339 · TERMINATED
Trial details
- NCT number
- NCT04564339
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2025-03-26
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.